ofatumumab

Ukraine

Drugs containing this active substance

  • BONSPRI

    It is used for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) accompanied by active disease.

    Form: solution for injection

    Active substance Dosage
    ofatumumab 20 mg/0.4 mL

    ATC: L04AA52

    Manufacturer: Novartis Pharma Stein AG (manufacturing, primary packaging, partial quality control, secondary packaging, batch release)